Goldman Sachs’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.58M Buy
576,276
+49,481
+9% +$291K ﹤0.01% 4192
2026
Q1
$2.33M Sell
526,795
-1,188,497
-69% -$7.03M ﹤0.01% 4405
2025
Q4
$9.18M Buy
1,715,292
+1,306,540
+320% +$10.4M ﹤0.01% 3171
2025
Q3
$3.93M Buy
408,752
+380,303
+1,337% +$3.51M ﹤0.01% 3865
2025
Q2
$209K Sell
28,449
-59,058
-67% -$396K ﹤0.01% 5642
2025
Q1
$410K Sell
87,507
-85,074
-49% -$425K ﹤0.01% 5305
2024
Q4
$782K Buy
172,581
+87,876
+104% +$468K ﹤0.01% 4991
2024
Q3
$235K Buy
84,705
+71,324
+533% +$190K ﹤0.01% 5397
2024
Q2
$40.9K Sell
13,381
-206,640
-94% -$797K ﹤0.01% 5481
2024
Q1
$909K Buy
+220,021
New +$679K ﹤0.01% 4406

Other funds holding ASPI

Goldman Sachs's ASPI Position: Q2 2026 in Review

Goldman Sachs increased its ASP Isotopes (ASPI) stake by 9.4% in Q2 2026, buying an estimated $291K and bringing the position to 576,276 shares worth $3.58M. The position accounts for ﹤0.01% of the portfolio, ranked #4192.

Goldman Sachs first reported a position in ASPI in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.18M in Q4 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Goldman Sachs held 576,276 shares of ASP Isotopes worth $3.58M as of Q2 2026.
  • Goldman Sachs bought 49,481 ASP Isotopes shares in Q2 2026, an estimated $291K.
  • ASP Isotopes made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4192 holding.
  • Goldman Sachs first reported a position in ASP Isotopes in Q1 2024 and has held it in 10 quarters since.
  • Goldman Sachs's ASP Isotopes position peaked at $9.18M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.